brain tumors Q28.2 D33 C71 C72 D33.4
Conditions
Interventions
Group 1: The CyberKnife Registry is an observational study, intending to register all pediatric patients who have been treated with Cyberknife radiosurgery for lesions in the central nervous system. P
Sponsors
Charité Campus Virchow-Klinikum
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Inclusion criteria
Inclusion criteria: age < 18, diagnosis of CNS lesion, interdisciplinary consent for radiosurgical intervention, possibility of consecutive follow up controls, consent form signed by both parents (and child depending on his/her age)
Exclusion criteria
Exclusion criteria: age of 18 or older, pregnancy, breast feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoints are complete remission and recidive at 1 and 2 years of follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end points are side effects, radiation toxicity and long-term effects | — |
Countries
Germany
Contacts
Public ContactLaura-Nanna Lohkamp
Charité-Universitätsmedizin Berlin, Klinik für Neurochirurgie
Outcome results
None listed